Interestingly, plasma levels of adiponectin appear to be progressively reduced in obese patients, obese patients with impaired fasting glycemia (IFG)/mild diabetes, and obese patients with T2D [41,68,69]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.